Gallium(III) complexes have emerged as promising candidates in bioinorganic chemistry due to their structural versatility, stability, and ability to mimic iron in biological systems, which allows them to interact selectively with key biomolecules. Motivated by these properties, we synthesized two novel gallium(III) complexes, Na[Ga(ida)2]·2H2O (1) and K[Ga(ida)2]·3H2O (2), employing iminodiacetate (ida2–) as the ligand. The synthesis of these complexes was carried out in aqueous solution by reacting GaCl3 with iminodiacetic acid (H2ida) at 80 °C for 4 h in the presence of NaOH or KOH, respectively. Their structures were determined using IR and NMR (1H and 13C) spectroscopy and further confirmed through single-crystal X-ray diffraction analysis. Building on this structural work, we investigated their interactions with bovine serum albumin (BSA) and calf thymus DNA (ct-DNA) using fluorescence emission spectroscopy to assess their binding affinity towards these biologically important molecules. Since serum albumin consists of three main domains (I–III), each subdivided into two subdomains (A and B), fluorescence competition experiments with site-specific markers were also performed to identify the preferred binding sites of the complexes. Eosin Y served as a marker for site I (subdomain IIA), ibuprofen for site II (subdomain IIIA), and digitoxin for site III (subdomain IB).
                    Previous Article in event
            
                            
    
                    Next Article in event
            
                            Next Article in session
            
                    
                                                    
        
                    DNA/BSA binding study of iminodiacetate-based gallium(III) complexes
                
                                    
                
                
                    Published:
29 October 2025
by MDPI
in The 1st International Electronic Conference on Medicinal Chemistry and Pharmaceutics
session Formulation, Drug Delivery and Controlled Release
                
                
                
                    Abstract: 
                                    
                        Keywords: BSA/DNA interactions; Iminodiacetate; Gallium(III) complexes; Site markers.
                    
                
                
                
                 
         
            



 
        
    
    
         
    
    
         
    
    
         
    
    
         
    
